Konjac glucomannan (KGM) is a water-soluble dietary fiber and is used for weight management. However, there is a lack of research on KGM for weight management in nonobese groups and the effects of high-dose KGM supplementation on liver function. This study investigated the metabolic responses to KGM intervention in obese and nonobese mice and explored the underlying mechanisms based on lipidomics. The findings demonstrated that KGM supplementation decreased body weight and mitigated lipid metabolism disorders at the mRNA and protein levels in obese mice. In contrast, no significant impact on these parameters was observed in nonobese mice. Interestingly, KGM had a more significant impact on remodeling hepatic lipid composition in obese mice compared to nonobese mice, leading to reducing harmful lipids and increasing beneficial lipids. However, high-dose KGM increased the risk of hepatocyte bile acid toxicity in obese mice and did not promote liver antioxidant status in nonobese mice. In summary, this study identified distinct metabolic responses to KGM intervention between obese and nonobese mice, providing insights for weight management using KGM.
Keyphrases
- weight loss
- body weight
- high fat diet induced
- high dose
- body mass index
- randomized controlled trial
- adipose tissue
- metabolic syndrome
- physical activity
- healthcare
- type diabetes
- magnetic resonance
- oxidative stress
- public health
- mental health
- bariatric surgery
- weight gain
- insulin resistance
- water soluble
- stem cell transplantation
- wild type
- fatty acid
- magnetic resonance imaging
- anti inflammatory
- climate change
- risk assessment
- amino acid
- drug induced